{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:09:45Z","timestamp":1788970185916,"version":"build-2803163510"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U54 HL 147127"],"award-info":[{"award-number":["U54 HL 147127"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Cigarette smoking is strongly associated with the development of cardiovascular disease (CVD). However, evidence is limited as to whether smokeless tobacco (ST) use is associated with CVD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims and Methods<\/jats:title>\n                  <jats:p>Using data from 4347 adults in the Population Assessment of Tobacco and Health Study (2013\u20132014), we compared geometric mean concentrations of CVD-related harm biomarkers and biomarkers of exposure among exclusive ST users and exclusive cigarette smokers\u2014in relation to recent nicotine exposure\u2014and never tobacco users, adjusting for age, sex, race\/ethnicity, income, body mass index, and CVD. Biomarker levels among exclusive ST users who were former established cigarette smokers were compared with exclusive cigarette smokers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with cigarette smokers, ST users had significantly higher concentrations of total nicotine equivalents (TNE) but lower concentrations of inflammatory (high-sensitivity C-reactive protein, interleukin-6, intercellular adhesion molecule, fibrinogen) and oxidative stress (8-isoprostane) biomarkers (all p &amp;lt; .05). Biomarker levels among ST users were similar to never smokers. ST users who were former cigarette smokers had lower levels of inflammatory and oxidative stress biomarkers and biomarkers of exposure (cadmium, lead, 1-hydroxypyrene, acrylonitrile, and acrolein), compared with cigarettes smokers (p &amp;lt; .05), despite having higher TNE levels (p &amp;lt; .05). Among cigarette smokers, but not among ST users, inflammatory biomarkers and TNE were highly correlated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ST use is not associated with increases in biomarkers of CVD-related harm and exposure, compared with never smokers, despite exposure to nicotine at levels higher than those observed among cigarette smokers. These findings support the concept that increases in CVD risk among cigarette smokers is caused primarily by constituents of tobacco smoke other than nicotine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>Despite having higher levels of nicotine and compared with exclusive cigarette smokers, exclusive ST users (including those who were former cigarette smokers) had significantly lower concentrations of inflammatory and oxidative stress biomarkers, comparable to levels observed among never tobacco users. These findings suggest that increases in CVD risk among cigarette smokers is caused primarily by tobacco constituents other than nicotine and that switching to ST is likely associated with lower CVD risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/ntab258","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T20:16:31Z","timestamp":1640290591000},"page":"1063-1070","source":"Crossref","is-referenced-by-count":15,"title":["Associations of Smokeless Tobacco Use With Cardiovascular Disease Risk: Insights From the Population Assessment of Tobacco and Health Study"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-5276","authenticated-orcid":false,"given":"Mary","family":"Rezk-Hanna","sequence":"first","affiliation":[{"name":"School of Nursing, University of California, Los Angeles , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umme Shefa","family":"Warda","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California, Los Angeles , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C","family":"Stokes","sequence":"additional","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fetterman","sequence":"additional","affiliation":[{"name":"Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California, Los Angeles , Los Angeles, CA , USA"},{"name":"Department of Environmental Health Sciences, Fielding School of Public Health, University of California, Los Angeles , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-7458","authenticated-orcid":false,"given":"Paul M","family":"Macey","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California, Los Angeles , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Darawad","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Jordan , Amman , Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-2323","authenticated-orcid":false,"given":"Yeonsu","family":"Song","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California, Los Angeles , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad","family":"Ben Taleb","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington , Arlington, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Lynn","family":"Brecht","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California, Los Angeles , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-8124","authenticated-orcid":false,"given":"Neal L","family":"Benowitz","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of California, San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"19","key":"2022061515185583600_CIT0001","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.2013.4412","article-title":"Temporal trends in smokeless tobacco use among US middle and high school students, 2000\u20132011","volume":"309","author":"Agaku","year":"2013","journal-title":"JAMA."},{"key":"2022061515185583600_CIT0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ypmed.2014.01.014","article-title":"Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus","volume":"62","author":"Lee","year":"2014","journal-title":"Prev Med."},{"issue":"4","key":"2022061515185583600_CIT0003","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMsa1607538","article-title":"Tobacco-product use by adults and youths in the United States in 2013 and 2014","volume":"376","author":"Kasza","year":"2017","journal-title":"N Engl J Med."},{"issue":"46","key":"2022061515185583600_CIT0004","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","article-title":"Tobacco product use among adults\u2014United States, 2019","volume":"69","author":"Cornelius","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"10","key":"2022061515185583600_CIT0005","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"2022061515185583600_CIT0006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"1","key":"2022061515185583600_CIT0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12954-019-0335-1","article-title":"Snus: a compelling harm reduction alternative to cigarettes","volume":"16","author":"Clarke","year":"2019","journal-title":"Harm Reduct J."},{"issue":"4","key":"2022061515185583600_CIT0008","doi-asserted-by":"crossref","first-page":"H801","DOI":"10.1152\/ajpheart.00591.2018","article-title":"Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation","volume":"316","author":"Conklin","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"15","key":"2022061515185583600_CIT0009","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIR.0b013e3181f432c3","article-title":"Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association","volume":"122","author":"Piano","year":"2010","journal-title":"Circulation."},{"issue":"6","key":"2022061515185583600_CIT0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tcm.2016.03.001","article-title":"Cardiovascular toxicity of nicotine: implications for electronic cigarette use","volume":"26","author":"Benowitz","year":"2016","journal-title":"Trends Cardiovasc Med."},{"issue":"3","key":"2022061515185583600_CIT0011","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.2007.01816.x","article-title":"Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men","volume":"262","author":"Hergens","year":"2007","journal-title":"J Intern Med."},{"issue":"6","key":"2022061515185583600_CIT0012","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/EDE.0b013e3181878b33","article-title":"Smokeless tobacco and the risk of stroke","volume":"19","author":"Hergens","year":"2008","journal-title":"Epidemiology."},{"issue":"4","key":"2022061515185583600_CIT0013","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10552-004-5519-6","article-title":"Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States)","volume":"16","author":"Henley","year":"2005","journal-title":"Cancer Causes Control."},{"issue":"3","key":"2022061515185583600_CIT0014","doi-asserted-by":"crossref","first-page":"pkz036","DOI":"10.1093\/jncics\/pkz036","article-title":"Contemporary associations of exclusive cigarette, cigar, pipe, and smokeless tobacco use with overall and cause-specific mortality in the United States","volume":"3","author":"Inoue-Choi","year":"2019","journal-title":"JNCI Cancer Spectr."},{"issue":"1","key":"2022061515185583600_CIT0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-019-0294-6","article-title":"Smokeless tobacco mortality risks: an analysis of two contemporary nationally representative longitudinal mortality studies","volume":"16","author":"Fisher","year":"2019","journal-title":"Harm Reduct J."},{"issue":"8","key":"2022061515185583600_CIT0016","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/aje\/kwf106","article-title":"Chronic disease mortality in a cohort of smokeless tobacco users","volume":"156","author":"Accortt","year":"2002","journal-title":"Am J Epidemiol."},{"issue":"6","key":"2022061515185583600_CIT0017","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0735-1097(99)00409-X","article-title":"Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men","volume":"34","author":"Huhtasaari","year":"1999","journal-title":"J Am Coll Cardiol."},{"issue":"6864","key":"2022061515185583600_CIT0018","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bmj.305.6864.1252","article-title":"Tobacco and myocardial infarction: is snuff less dangerous than cigarettes?","volume":"305","author":"Huhtasaari","year":"1992","journal-title":"BMJ."},{"issue":"7","key":"2022061515185583600_CIT0019","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/01.STR.0000076011.02935.A1","article-title":"Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study","volume":"34","author":"Asplund","year":"2003","journal-title":"Stroke."},{"issue":"6","key":"2022061515185583600_CIT0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/14034940701436949","article-title":"Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden","volume":"35","author":"Haglund","year":"2007","journal-title":"Scand J Public Health."},{"issue":"8","key":"2022061515185583600_CIT0021","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2105\/AJPH.79.8.1048","article-title":"Use of smokeless tobacco, cigarette smoking, and hypercholesterolemia","volume":"79","author":"Tucker","year":"1989","journal-title":"Am J Public Health."},{"issue":"9","key":"2022061515185583600_CIT0022","first-page":"895","article-title":"Lipid profile in smokers and tobacco chewers\u2014a comparative study","volume":"48","author":"Khurana","year":"2000","journal-title":"J Assoc Physicians India."},{"issue":"6","key":"2022061515185583600_CIT0023","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2796.2001.00917.x","article-title":"Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men","volume":"250","author":"Wallenfeldt","year":"2001","journal-title":"J Intern Med."},{"issue":"1","key":"2022061515185583600_CIT0024","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12864-017-3565-1","article-title":"Gene expression profiles associated with cigarette smoking and moist snuff consumption","volume":"18","author":"Arimilli","year":"2017","journal-title":"BMC Genomics."},{"key":"2022061515185583600_CIT0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2017.11.013","article-title":"Inflammatory profile analysis reveals differences in cytokine expression between smokers, moist snuff users, and dual users compared to non-tobacco consumers","volume":"107","author":"Sgambato","year":"2018","journal-title":"Cytokine."},{"key":"2022061515185583600_CIT0026","first-page":"12","volume-title":"Health Hazards of Moist Snuff","author":"Ahlbom","year":"1997"},{"issue":"2","key":"2022061515185583600_CIT0027","doi-asserted-by":"crossref","first-page":"e000846","DOI":"10.1136\/openhrt-2018-000846","article-title":"Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis","volume":"5","author":"Rostron","year":"2018","journal-title":"Open Heart."},{"key":"2022061515185583600_CIT0028","volume-title":"Population Assessment of Tobacco and Health (PATH) Study [United States] Biomarker Restricted-Use Files (ICPSR36840)","author":"National Institute on Drug Abuse, Food and Drug Administration, Center for Tobacco Products","year":"2017"},{"key":"2022061515185583600_CIT0029","author":"National Addiction and HIV Data Archive Program (NAHDAP)"},{"issue":"4","key":"2022061515185583600_CIT0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00216-016-9933-x","article-title":"Quantification of urinary mono-hydroxylated metabolites of polycyclic aromatic hydrocarbons by on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry","volume":"409","author":"Wang","year":"2017","journal-title":"Anal Bioanal Chem."},{"issue":"1","key":"2022061515185583600_CIT0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.57.1.3","article-title":"Metabolism and disposition kinetics of nicotine","volume":"57","author":"Hukkanen","year":"2005","journal-title":"Pharmacol Rev."},{"issue":"17","key":"2022061515185583600_CIT0032","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.3390\/ijerph17176403","article-title":"Biomarkers of exposure among USA adult hookah users: results from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013\u20132014)","volume":"17","author":"Travers","year":"2020","journal-title":"Int J Environ Res Public Health."},{"issue":"18","key":"2022061515185583600_CIT0033","doi-asserted-by":"crossref","first-page":"e012729","DOI":"10.1161\/JAHA.119.012729","article-title":"Racial differences in cardiovascular biomarkers in the general population","volume":"8","author":"Hackler","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"2022061515185583600_CIT0034","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/JIR.S294368","article-title":"Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort","volume":"14","author":"Cohen","year":"2021","journal-title":"J Inflamm Res."},{"issue":"5","key":"2022061515185583600_CIT0035","doi-asserted-by":"crossref","first-page":"e002623","DOI":"10.1136\/bmjopen-2013-002623","article-title":"Contributions of body mass index and exercise habits on inflammatory markers: a cohort study of middle-aged adults living in the USA","volume":"3","author":"Strohacker","year":"2013","journal-title":"BMJ Open."},{"issue":"8","key":"2022061515185583600_CIT0036","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1055-9965.EPI-07-0227","article-title":"Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers","volume":"16","author":"Hecht","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"12","key":"2022061515185583600_CIT0037","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1055-9965.EPI-15-0376","article-title":"Nicotine and toxicant exposure among U.S. smokeless tobacco users: results from 1999 to 2012 National Health and Nutrition Examination Survey Data","volume":"24","author":"Rostron","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"3","key":"2022061515185583600_CIT0038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/1354750X.2010.546013","article-title":"Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999\u20132008","volume":"16","author":"Naufal","year":"2011","journal-title":"Biomarkers."},{"issue":"12","key":"2022061515185583600_CIT0039","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1080\/14622200802443544","article-title":"New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels","volume":"10","author":"Stepanov","year":"2008","journal-title":"Nicotine Tob Res."},{"issue":"14","key":"2022061515185583600_CIT0040","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N Engl J Med."},{"issue":"15","key":"2022061515185583600_CIT0041","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation."},{"issue":"2","key":"2022061515185583600_CIT0042","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2008.109728","article-title":"The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines","volume":"55","author":"Mora","year":"2009","journal-title":"Clin Chem."},{"issue":"5","key":"2022061515185583600_CIT0043","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J Am Coll Cardiol."},{"issue":"13","key":"2022061515185583600_CIT0044","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2010.10.043","article-title":"Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality","volume":"57","author":"M\u00f6hlenkamp","year":"2011","journal-title":"J Am Coll Cardiol."},{"issue":"9709","key":"2022061515185583600_CIT0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet."},{"issue":"1","key":"2022061515185583600_CIT0046","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(03)00280-6","article-title":"Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study","volume":"170","author":"Luc","year":"2003","journal-title":"Atherosclerosis."},{"key":"2022061515185583600_CIT0047","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijcard.2018.08.002","article-title":"Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: results from a large cohort study","volume":"273","author":"Xuan","year":"2018","journal-title":"Int J Cardiol."},{"key":"2022061515185583600_CIT0048","author":"Statistics Sweden"},{"issue":"4","key":"2022061515185583600_CIT0049","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.113.007252","article-title":"Discontinuation of smokeless tobacco and mortality risk after myocardial infarction","volume":"130","author":"Arefalk","year":"2014","journal-title":"Circulation."},{"key":"2022061515185583600_CIT0050","doi-asserted-by":"crossref","first-page":"b3060","DOI":"10.1136\/bmj.b3060","article-title":"Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis","volume":"339","author":"Boffetta","year":"2009","journal-title":"BMJ."},{"issue":"10","key":"2022061515185583600_CIT0051","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10654-012-9704-8","article-title":"Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies","volume":"27","author":"Hansson","year":"2012","journal-title":"Eur J Epidemiol."},{"issue":"1","key":"2022061515185583600_CIT0052","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/clpt.1988.107","article-title":"Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum","volume":"44","author":"Benowitz","year":"1988","journal-title":"Clin Pharmacol Ther."},{"issue":"14","key":"2022061515185583600_CIT0053","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","article-title":"Tobacco smoke carcinogens and lung cancer","volume":"91","author":"Hecht","year":"1999","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"2022061515185583600_CIT0054","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2174\/138945012800399008","article-title":"The Yin and Yang of non-neuronal \u03b17-nicotinic receptors in inflammation and autoimmunity","volume":"13","author":"Filippini","year":"2012","journal-title":"Curr Drug Targets."},{"key":"2022061515185583600_CIT0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.envint.2018.12.052","article-title":"Children environmental exposure to particulate matter and polycyclic aromatic hydrocarbons and biomonitoring in school environments: a review on indoor and outdoor exposure levels, major sources and health impacts","volume":"124","author":"Oliveira","year":"2019","journal-title":"Environ Int."},{"issue":"2","key":"2022061515185583600_CIT0056","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/tc.2008.028209","article-title":"Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results?","volume":"18","author":"Zhu","year":"2009","journal-title":"Tob Control."},{"issue":"1","key":"2022061515185583600_CIT0057","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-2797(02)00162-X","article-title":"Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic\/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis","volume":"145","author":"Crowley-Weber","year":"2003","journal-title":"Chem Biol Interact."},{"issue":"7","key":"2022061515185583600_CIT0058","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1158\/1055-9965.EPI-20-1544","article-title":"Biomarkers of potential harm among adult cigarette and smokeless tobacco users in the PATH Study Wave 1 (2013\u20132014): a cross-sectional analysis","volume":"30","author":"Chang","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev."}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntab258\/42092439\/ntab258.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/24\/7\/1063\/44081415\/ntab258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/24\/7\/1063\/44081415\/ntab258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T15:23:30Z","timestamp":1655306610000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/24\/7\/1063\/6499417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,1,6]]},"published-print":{"date-parts":[[2022,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntab258","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,1,6]]}}}